Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal atropine to prevent nausea and vomiting after intrathecal morphine in lower limb surgeries
IRCT2013012012204N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Mar 2013
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atropine in postoperative nausea and vomiting (PONV) and adverse effect, sponsored by Qazvin University of Medical Sciences. Started Mar 2013; status: completed.
02
Drugs
atropine
03
Conditions
postoperative nausea and vomiting (PONV)adverse effect
Beyond the preview
Go deeper on IRCT2013012012204N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013012012204N1.